PRECIPIO, INC. Induced Conversion of Convertible Debt Expense
PRECIPIO, INC. (PRPO) reported Induced Conversion of Convertible Debt Expense of $1.87 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InducedConversionOfConvertibleDebtExpense · last filed 2021-03-29
- PRECIPIO, INC. induced conversion of convertible debt expense for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. induced conversion of convertible debt expense for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. induced conversion of convertible debt expense for the quarter ending 2019-06-30 was $1.87M, a 101.51% increase year-over-year.
- PRECIPIO, INC. induced conversion of convertible debt expense for the quarter ending 2018-12-31 was $288.00K.
- PRECIPIO, INC. induced conversion of convertible debt expense for fiscal 2019 was $1.87M, a 40.81% increase from fiscal 2018.
- PRECIPIO, INC. induced conversion of convertible debt expense for fiscal 2018 was $1.33M.
| Period end | Induced Conversion of Convertible Debt Expense 3 month | Induced Conversion of Convertible Debt Expense 6 month | Induced Conversion of Convertible Debt Expense 9 month | Induced Conversion of Convertible Debt Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 derived: sum of 2 quarters · filed 2021-03-29 | $1.87M derived: sum of 3 quarters · filed 2021-03-29 | $1.87M 10-K · filed 2021-03-29 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.87M derived: sum of 2 quarters · filed 2020-11-13 | $1.87M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $1.87M 10-Q · filed 2020-08-13 | $1.87M 10-Q · filed 2020-08-13 | ||
| 2018-12-31 | $288.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $400.00K derived: sum of 2 quarters · filed 2020-03-27 | $1.33M derived: sum of 3 quarters · filed 2020-03-27 | $1.33M 10-K · filed 2020-03-27 |
| 2018-09-30 | $112.00K 10-Q · filed 2019-11-13 | $1.04M derived: sum of 2 quarters · filed 2019-11-13 | $1.04M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $928.00K 10-Q · filed 2019-08-09 | $928.00K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |